New Mexico health department draft psilocybin rules draw rebuke at public hearing
New Mexico Medical Psilocybin Program Regulation Changes Spark Outcry
Medical providers, veterans, legal experts and the legislative sponsor of New Mexico's Medical Psilocybin Act criticised draft rules 7.35.3 and 7.35.2 NMAC at an Oct. 2 public hearing before the New Mexico Department of Health, arguing the proposed prescriber gateway, landlord consent requirements and staffing ratios exceed the statute and could block access. The department is accelerating the program's launch to December 2026, a year ahead of the statutory deadline. Speakers said the rules would require an in-person exam with a certifying clinician, patient identification cards and up to 30 days of state review, and that landlord sign-off for homebound patients and leased healing centres conflicts with fair housing law; some clinical educators praised the draft training and supervision standards. Sixteen advocacy and clinical organisations have asked Rep. Nathan P. Small to add $500,000 for the Treatment Equity Fund and $500,000 for University of New Mexico palliative research.
Key facts
- Kind of item
- Guidance and consultations
- Compound
- Psilocybin
- Conditions
- Depression, PTSD, End-of-life distress
- Jurisdiction
- United States
- Source
- Lucid News (lucid.news)
- Published
- Original
- Read it at lucid.news
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Lucid News · lucid.news
Connected to
- Kind of item
- Guidance and consultations
- Compound
- Psilocybin
- Conditions
- DepressionPTSDEnd-of-life distress
- Jurisdiction
- United States